ApprovalTrail

Approval · Notice of Compliance 10229 · 2009

ONCOTICE: Notice of Compliance 10229

Issued June 1, 2009

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
10229
Date
June 1, 2009
Company
Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
Product type
Biologic
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Antineoplastic agent for bladder instillation

Products in this notice

BrandDINStatus today
ONCOTICE02153513Marketed

Medicinal ingredients